Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-02 11:56 am Sale | 13G | Apyx Medical Corp APYX | Cowen Financial Products LLC | 0 0% | -1,775,793 (Position Closed) | View |
2024-02-02 11:55 am Sale | 13G | African Gold Acquisition Corp AGAC | Cowen Financial Products LLC | 0 0% | -330,000 (Position Closed) | View |
2024-02-02 11:49 am Sale | 13G | ADICET BIO INC ACET | Cowen Financial Products LLC | 2,715,278 6.29% | -428,330 (-13.63%) | View |
2023-12-14 4:04 pm Unchanged | 13G | Canna-Global Acquisition Corp CNGL | Cowen Financial Products LLC | 200,000 10.1% | 0 (Unchanged) | View |
2023-08-11 3:00 pm Unchanged | 13G | PROJECT ENERGY REIMAGINED ACQ. PEGR | Cowen Financial Products LLC | 1,500,000 8.6% | 0 (Unchanged) | View |
2023-05-05 3:28 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,398,983 5.22% | 1,398,983 (New Position) | View |
2023-04-19 11:05 am Purchase | 13G | African Gold Acquisition Corp AGAC | Cowen Financial Products LLC | 330,000 6.2% | 330,000 (New Position) | View |
2023-04-11 3:54 pm Purchase | 13G | GLOBAL PARTNER ACQUISITION COR GPAC | Cowen Financial Products LLC | 200,000 5.08% | 200,000 (New Position) | View |
2023-04-11 3:50 pm Purchase | 13G | Canna-Global Acquisition Corp CNGL | Cowen Financial Products LLC | 200,000 6.3% | 200,000 (New Position) | View |
2023-03-02 4:55 pm Purchase | 13G | VERANO HLDGS CORP COM SUB VTG VRNOF | Cowen Financial Products LLC | 16,497,443 5.025% | 16,497,443 (New Position) | View |
2023-02-27 10:06 am Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Cowen Financial Products LLC | 2,407,562 7.07% | 2,407,562 (New Position) | View |
2023-02-16 1:52 pm Purchase | 13G | Sylvamo Corp SLVM | Cowen Financial Products LLC | 2,150,000 5.04% | 2,150,000 (New Position) | View |
2023-01-26 10:25 am Sale | 13G | DTRT Health Acquisition Corp. DTRT | Cowen Financial Products LLC | 224,845 6.98% | -75,155 (-25.05%) | View |
2023-01-25 5:30 pm Sale | 13G | TPCO HLDG CORP GRAMF | Cowen Financial Products LLC | 0 0% | -5,592,948 (Position Closed) | View |
2023-01-25 3:57 pm Unchanged | 13G | GOODNESS GROWTH HLDGS INC GDNSF | Cowen Financial Products LLC | 0 0% | 0 (Unchanged) | View |
2023-01-25 3:53 pm Unchanged | 13G | VEXT SCIENCE INC VEXTF | Cowen Financial Products LLC | 4,856,256 6.88% | 0 (Unchanged) | View |
2023-01-25 3:51 pm Purchase | 13G | Trulieve Cannabis Corp. TRUL | Cowen Financial Products LLC | 11,148,292 6.98% | 4,101,929 (+58.21%) | View |
2023-01-25 3:47 pm Sale | 13G | TERRASCEND CORP TSNDF | Cowen Financial Products LLC | 9,616,988 3.8% | -2,014,042 (-17.32%) | View |
2023-01-25 3:45 pm Sale | 13G | Stoke Therapeutics Inc. STOK | Cowen Financial Products LLC | 1,248,077 1.89% | -623,452 (-33.31%) | View |
2023-01-24 2:52 pm Unchanged | 13G | SOL GLOBAL INVTS CORP COM SOLCF | Cowen Financial Products LLC | 3,434,625 6.31% | 0 (Unchanged) | View |